In vitro lysis of fibrin, as indicated by increased fibrinogen-fibrin-related antigen (FR-antigen)
in serum is usually seen when whole blood, or plasma, or highly purified fibrinogen …

Fresh citrated or EDTA plasma, saturated with soluble fibrin by incubating with traces of
thrombin gelled upon the addition of ethanol at 20° C ('the ethanol gelation test'). Upon …

The determination of plasma fibrinogen as clottable protein, as precipitable protein, and by
the reaction rate in the conversion of fibrinogen to fibrin is evaluated in terms of the …

The presence in serum of non-thrombin-clottable antigens to antifibrin antibody may have
considerable diagnostic significance since excessive amounts commonly occur in patients …

The antigens in thrombin-treated human serum which react with antifibrin or antifibrinogen
serum have customarily been referred to as fibrinolytic degradation (or split) products (FDP) …

FIBRINOLYTIC activity arising in vivo is notoriously difficult to demonstrate. Even when it
seems obvious that there has been fibrinolysis in vivo, serum taken from the patient may fail …

Purified fibrinogen and fibrin, and the clottable proteins of normal plasma, have been
examined by quantitative N-terminal amino acid analysis. When normal plasma was …

Detection of fibrin in plasma by a monoclonal antibody against the amino-terminus of the
alpha-chain of fibrin. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Fibrinogen-coated cells stored at 4 C for five months retained an unchanged capacity to
react in the test. When they were left at room temperature for only a few days, however, they …

In several diseases, such as disseminated intravascular coagulation, fibrin-fibrinogen
degradation products (FDP) can be detected when serum is used. To avoid the use of serum …